Atherosclerosis Drugs Market: The Race for Innovation and Market Leadership
The atherosclerosis drugs market is currently experiencing significant transformations, driven by an increasing prevalence of cardiovascular diseases (CVDs) globally. As one of the leading causes of death worldwide, atherosclerosis – the condition where plaque builds up inside the arteries – has become a focal point for pharmaceutical companies. The market is competitive, with...
0
0
1252